NCT02588430Withdrawn
PMCF Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMS
Post-Market Clinical Follow-up Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMS
Source: ClinicalTrials.gov · Last updated 19 Apr 2019
Brief summary (registry, in English)
This study is a post-market clinical follow-up (PMCF) study to monitor the safety, lifetime and efficacy of patients using the CE-certified RETINA IMPLANT Alpha AMS.
- Status (registry)
- Withdrawn
- Study type
- Observational
- Enrollment
- 0 (actual)
- First submitted
- 30 Sept 2014
- Start date
- Mar 2019
- Primary completion date
- Dec 2029
- Lead sponsor
- Retina Implant AG
- Diseases
- Retinitis pigmentosa
- NCT number
- NCT02588430
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- none
Who the study is looking for
- Patients who received a RETINA IMPLANT Alpha AMS.
- Patients willing and able to give written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Katharinenhospital Stuttgart | Stuttgart | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.